He obtained his doctoral degree at CTM two years ago and has since become a supervisor, supporting students’ research with his expertise. He has two Ph.D. students at the Centre, both of whom are making good progress with their research in urology. Tamás Fazekas was honored with the Excellent Supervisor Award by the Centre for Translational Medicine.
Dr. Fazekas had already been familiar with CTM’s Ph.D. program before joining it as a supervisor, as he had earned his doctoral degree at the Center two years ago. In his dissertation, he researched prostate cancer – the most common malignancy in men – and published his findings in the most prestigious scientific journals. As a supervisor, he has two students: Andras Négyessy and Nikolett Pribus.
“Dr. Négyessy joined our program from the University of Szeged, where he works as a urology resident. Since he is a very motivated and well-prepared colleague, I was happy to become his supervisor. He became involved in my research on prostate cancer, and through his own projects, he hopes to make prostate cancer screening and treatment even more effective. In his first project, he is investigating the diagnostic accuracy of new biomarkers in prostate cancer screening. His results show that if a PSA test indicates potential risk, it is worth testing the patient for these new biomarkers. This helps avoid unnecessary MRI scans and biopsies. We believe that the guidelines should implement these new biomarkers for prostate cancer screening.” Dr. Négyessy has already started his second project, in which he is investigating the cardiovascular effects induced by androgen deprivation therapy and androgen receptor pathway inhibitors in patients with prostate cancer. The results of this research are very encouraging and may help improve long-term patient care in collaboration with cardiologists.
Nikolett Pribus works as a nurse at the University of Szeged, and she joined CTM’s Ph.D. program alongside her clinical duties. “In her research, she is assessing how mortality and postoperative complications in urology patients can be reduced through various perioperative care programs. In her first project, she is investigating the effectiveness of Enhanced Recovery After Surgery (ERAS) in patients undergoing radical urological procedures, such as cystectomy, prostatectomy, nephrectomy, and nephroureterectomy. She assumes that using the ERAS protocol helps reduce the rate of complications following such surgeries. If this is confirmed, the protocol could be used for a broader spectrum of surgeries beside cystectomy.”
(Emese Szabó)